ArticleClinical and molecular hepatology2025

Interventions targeting the gut-liver axis: A potential treatment strategy for metabolic dysfunction-associated steatotic liver disease.

Pingping Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.